help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramamoorthy, K.
Right arrow Articles by Safe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramamoorthy, K.
Right arrow Articles by Safe, S.
Endocrinology Vol. 138, No. 4 1520-1527
Copyright © 1997 by The Endocrine Society


ARTICLES

Estrogenic Activity of a Dieldrin/Toxaphene Mixture in the Mouse Uterus, MCF-7 Human Breast Cancer Cells, and Yeast-Based Estrogen Receptor Assays: No Apparent Synergism1

Kavita Ramamoorthy, Fan Wang, I-Chen Chen, John D. Norris, Donald P. McDonnell, Linda S. Leonard, Kevin W. Gaido, Wayne P. Bocchinfuso, Kenneth S. Korach and Stephen Safe2

Veterinary Physiology and Pharmacology (K.R., F.W., I-C.C, S.S), Texas A&M University, College Station, Texas 77843-4466; Department of Pharmacology (J.D.N., D.P.M.), Duke University Medical School, Durham, North Carolina 27709; Chemical Industry Institute of Toxicology (L.S.L., K.W.G.), Research Triangle Park, North Carolina 27709; and Laboratory of Reproductive and Developmental Toxicology (W.P.B., K.S.K.), National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709

Address all correspondence and requests for reprints to: Stephen Safe, Veterinary Physiology and Pharmacology, Texas A&M University, College Station, Texas 77843-4466.


    Abstract
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
The estrogenic activity of dieldrin, toxaphene, and an equimolar mixture of both compounds (dieldrin/toxaphene) was investigated in the 21-day-old B6C3F1 mouse uterus, MCF-7 human breast cancer cells, and in yeast-based reporter gene assays. Treatment of the animals with 17ß-estradiol (E2) (0.0053 kg/day x3) resulted in a 3.1-, 4.8-, and 7.8-fold increase in uterine wet weight, peroxidase activity, and progesterone receptor binding, respectively. In contrast, treatment with 2.5, 15 and 60 µmol/kg (x3) doses of toxaphene, dieldrin, or dieldrin/toxaphene (equimolar) did not significantly induce a dose-dependent increase in any of the E2-induced responses. The organochlorine pesticides alone and the binary mixture did not bind to the mouse uterine estrogen receptor (ER) in a competitive binding assay using [3H]E2 as the radioligand. In parallel studies, estrogenic activities were determined in MCF-7 cells by using a cell proliferation assay and by determining induction of chloramphenicol acetyl transferase (CAT) activity in MCF-7 cells transiently transfected with plasmids containing estrogen-responsive 5'-promoter regions from the rat creatine kinase B and human cathepsin D genes. E2 caused a 24-fold increase in CAT activity in MCF-7 cells transiently transfected with creatine kinase B and a 3.8-fold increase in cells transiently transfected with the human cathepsin D construct. Treatment of MCF-7 cells with dieldrin, toxaphene, or an equimolar mixture of dieldrin plus toxaphene (10-8–10-5 M) did not significantly induce cell proliferation or CAT activity in the transient transfection experiment with both plasmids. The relative competitive binding of the organochlorine pesticides was determined by incubating MCF-7 cells with 10-9 M [3H]E2 in the presence or absence of 2 x 10-7 M unlabeled E2 (to determine nonspecific binding), toxaphene (10-5 M), dieldrin (10-5 M), and equimolar concentrations of the dieldrin plus toxaphene mixture (10-5 M). The binding observed for [3H]E2 in the whole cell extracts was displaced by unlabeled E2, whereas the organochlorine pesticides and binary mixture exhibited minimal to nondetectable competitive binding activity. E2 caused a 5000-fold induction of ß-galactosidase (ß-gal) activity in yeast transformed with the human ER and a double estrogen responsive element upstream of the ß-gal reporter gene. Treatment with 10-6–10-4 M chlordane, dieldrin, toxaphene, or an equimolar mixture of dieldrin/toxaphene did not induce activity, whereas 10-4 M endosulfan caused a 2000-fold increase in ß-gal activity. Diethylstilbestrol caused a 20-fold increase in activity in yeast transformed with the mouse ER and a single estrogen responsive element upstream of the ß-gal reporter gene. Dieldrin, chlordane, toxaphene, and endosulfan induced a 1.5- to 4-fold increase in activity at a concentration of 2.5 x 10-5 M. Synergistic transactivation was not observed for any equimolar binary mixture of the pesticides at concentrations of either 2.5 x 10-5 M or 2.5 x 10-4 M. The results of this study demonstrate that for several estrogen-responsive assays in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based reporter gene assays, the activities of both dieldrin and toxaphene were minimal, and no synergistic interactions were observed with a binary mixture of the two compounds.


    Introduction
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
COLBORN and co-workers (1) have summarized results from several studies reporting developmental effects of endocrine-disrupting chemicals on some wildlife populations. Environmental contaminants that modulate endocrine response pathways include persistent organochlorine compounds such as 1,1,1-trichloro-2,2-bis(p-chlorophenyl)ethane (DDT), 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene, other isomeric DDT/1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene analogs, polychlorinated biphenyls (PCBs), hydroxy-PCBs, 2,3,7,8-tetrachlorodibenzo-p-dioxin, and related halogenated aromatic hydrocarbons (1, 2). Many of the organochlorine compounds, some phthalates, and industrial phenolics (bisphenol-A and nonylphenol) exhibit estrogenic activity (3, 4, 5, 6, 7, 8, 9, 10), and it has been hypothesized that xenoestrogens may play a role in wildlife reproduction problems, decreased male reproductive capacity, and the increased incidence of breast cancer in women (1, 11, 12, 13). The hypothesized role of xenoestrogens in human disease has been challenged (14, 15, 16, 17), and further research is required to substantiate or disprove the hypothesis.

A recent study by Arnold and co-workers (18) reported synergistic interactions of binary mixtures of endosulfan, dieldrin, toxaphene, and chlordane in competitive estrogen receptor (ER)-binding assays and in an estrogen-responsive assay in yeast. Less dramatic synergistic interactions between two weakly estrogenic hydroxy PCB congeners were observed also in the yeast assay and in human endometrial cancer cells. Synergistic interactions between estrogenic chemicals have been reported also in other studies using a single concentration of several compounds and their reconstituted mixtures (6, 10, 19); however, the study by Arnold and coworkers (18) reported dramatic synergistic interactions (up to 1600-fold) by comparing the concentration-dependent effects of individual compounds and their binary mixtures. Based on these data, it was suggested that the estrogenic potency of some environmental chemicals, when tested singly, may be underestimated (18). This study has used two compounds, dieldrin and toxaphene, which gave synergistic responses as a binary mixture in the yeast and ER-binding assays in the study reported by Arnold and co-workers (18). The results of this study show that in the mouse uterus, interactions of dieldrin and toxaphene in ER-binding and functional assays were not synergistic; moreover, similar results were observed in MCF-7 human breast cancer cells and yeast-based reporter gene assays using both the mouse and human ER. Thus, the synergistic interactions of weakly estrogenic environmental chemicals are not universally observed in estrogen-responsive assays, and this should be considered in hazard assessment of these environmental contaminants.


    Materials and Methods
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Chemicals and biochemicals
Dieldrin, endosulfan, chlordane, and toxaphene (technical) were purchased from Chem-Service (West Chester, PA). MCF-7 human breast cancer cells were purchased from the American Type Culture Collection (ATCC, Rockville, MD). DMEM nutrient mixture F-12 Ham (DME/F-12) without phenol red, PBS, acetyl CoA, 17ß-estradiol (E2), and 100X antibiotic/antimycotic solution were purchased from Sigma Chemical Company (St. Louis, MO). FBS was obtained from Intergen (Purchase, NY). MEM was purchased from Life Technologies (Grand Island, NY); [14C]chloramphenicol (53 mCi/mmol) and [3H]R5020 (86.7 Ci/mmol) were purchased from NEN Research Products (Boston, MA) and [3H]E2 (130 Ci/mmol) was purchased from Amersham Life Sciences (Arlington Heights, IL). The human cathepsin (CATH-CAT) construct contains a cathepsin D promoter insert (-365 to -10) (20) ligated into a pBL/TATA/chloramphenicol acetyl transferase (CAT) plasmid derived from pBL/CAT2. The creatine kinase B (CKB-CAT) construct contains a 2.9-kilobase rat CKB-CAT construct provided by Dr. P. Benfield (Dupont Corp.) (21). All other chemicals and biochemicals were of the highest quality available from commercial sources.

Animals
B6C3F1 female mice were bred in an onsite animal facility and housed 6 to 9 per cage with ad libitum access to food and water. Test compounds were dissolved in corn oil with slight warming, and mice (n = 6–9 per group) received 0.1 ml corn oil (control), E2 at a dose of 0.0053 µmol/kg·day, toxaphene (2.5, 15, 60, or 275 µmol/kg), dieldrin, or an equimolar toxaphene-dieldrin mixture. The mixture was derived by combining equal molar combinations of toxaphene and dieldrin. The solutions (0.1 ml per animal) were administered ip for 3 consecutive days starting at 21 days of age. Animals were killed by CO2 asphyxiation 20 h after the last treatment, and uteri were excised, blotted, and weighed. The uteri were then placed in ice-cold buffer and bisected, such that each half contained an entire uterine horn.

Cell proliferation assay
MCF-7 cells (50,000) were seeded in six-well multiwell plates in media containing 2 ml DME/F12 without phenol red, supplemented with 5% FBS treated with dextran-coated charcoal (FBS-DCC), 2.2 g/liter sodium bicarbonate, 10 mg/liter apotransferrin, and 20 µg/ml BSA. After 24 h, the media was changed, and the cells were treated with 10-9 M E2, 10-7–10-5 M concentrations of toxaphene, dieldrin, or dieldrin plus toxaphene (equimolar concentrations). The media and chemical treatment were changed every 2 days, and the total duration of the proliferation experiments was 11 days. Cells were then trypsinized, washed with media, resuspended in 1 ml of media, and counted using a Coulter counter, as previously described (22). All determinations were carried out in triplicate, and results are expressed as means ± SD.

Transient transfection assays
MCF-7 cells for proliferation and transient transfection studies were maintained in MEM with phenol red and supplemented with 10% FCS plus antibiotic/antimycotic solution, 0.035% sodium bicarbonate, 0.011% sodium pyruvate, 0.1% glucose, 0.238% HEPES, and 6 x 10-7% insulin. MCF-7 cells were then trypsinized, reseeded in 100-mm petri dishes with 10 ml of phenol red-free DME/F-12 medium plus 5% charcoal-stripped FBS, and grown until 50–60% confluent. About 3 h before transfection, medium was replaced with 5 ml charcoal-stripped DME/F-12 medium. Cells in each petri dish were transfected with 1 ml transfection cocktail containing either 10 µg CKB-CAT plus 5 µg hER or 5 µg CATH-CAT plus 4 µg hER, 50 µl of 2.5 M CaCl2, and 500 µl HBS (pH 7.05). After incubation for 14 to 16 h at 37 EC, cells were washed once with 5 ml PBS and treated with test chemicals in 10 ml DCC-stripped DME/F-12 medium. After 48 h, cells were washed once with 5 ml PBS and harvested by scrapping. Cells were lysed in 200 µl of 0.25 M Tris-Cl (pH 7.6) by three cycles of freezing in liquid nitrogen for 2 min, thawing at 37 EC for 2 min, sonication for 3 min, and vortexing for 1 min. Cell debris was pelleted, and the protein concentration in the supernatant was determined (23) using BSA as standard. An aliquot of cell lysate equal to 80 µg protein was diluted to 120 µl with 0.25 M Tris-Cl (pH 7.6) and incubated with 1 µl [14C]chloramphenicol (53 mCi/mmol) and 42 µl of 4 mM acetyl CoA for 6 h at 37 EC. The reaction was stopped by vortexing with 700 µl ethyl acetate. The extract (600 µl) was dried, redissolved in 20 µl ethyl acetate, and the acetylated products resolved by TLC (Whatman Lab Sales, Hillsboro, OR) using a 95:5 chloroform:methanol solvent mixture. The percent protein conversion into acetylated chloramphenicol was quantitated using the counts/minute obtained from the Betagen Betascope 603 blot analyzer (Intelligenetics, Inc., Mountain View, CA). The TLC plates were subjected to autoradiography using a Kodak X-Omat film (Eastman Kodak Co., Rochester, NY) for about 20 h.

Progesterone (PR) and ER-binding assays
The uterine bisections of each treatment group were pooled in an ice-cold TESHMo (10 mM Tris-Cl, pH 7.4, 1.5 mM EDTA, 15 mM thioglycerol, 10 mM sodium molybdate) buffer, 1 ml/50 mg tissue. Uteri were homogenized with 3 x 8-sec bursts using a Brinkman/Polytron tissue grinder (Brinkman Instruments Co., Westbury, NY). Samples were then centrifuged for 45 min at 105,000 x g, and the clear supernatant, constituting the cytosol for this experiment, was carefully decanted and immediately used for competitive binding assays. Cytosolic fractions described above were incubated with 20 nM [3H]R5020 in the presence or absence of 2 µM unlabeled R5020 at 4 EC. After an 8-h incubation, samples were placed on ice and treated with 0.1 vol DCC suspension (0.5% dextran:5% charcoal, wt/vol in TESHMo) for 10 min. Samples were then centrifuged at 5,000 x g for 10 min, and the supernatant was measured by liquid scintillation counting. PR levels were calculated assuming a 1:1 binding between PR and [3H]R5020. Levels are reported in femtomoles per uterus. [3H]E2 (10-8 M) was used as a radioligand for determining the competitive displacement of [3H]E2 by different concentrations of the test compounds. Uterine cytosol for ER binding was obtained from untreated animals.

Uterine peroxidase (UPO) assay
Uterine bisections were pooled into treatment groups and homogenized as described above. Homogenates were centrifuged at 39,000 x g at 2 EC for 45 min, and the resulting pellet was washed and resuspended in 10 mM Tris-Cl buffer containing 0.5 M CaCl2. The extract was clarified by centrifugation for 45 min at 39,000 x g at 2 EC. UPO activity of the supernatant was determined as described (24). The assay mixture (3.0 ml total) contained 13 mM guaiacol and 0.3 mM H2O2 in the extraction buffer. The reaction was started by addition of 1.0 ml of the CaCl2 extract. The initial rate (1 min) of guaiacol oxidation was monitored at {lambda} = 470 nm on a Beckman spectrophotometer (Beckman Instruments Inc., Fullerton, CA). An enzyme unit was defined as the amount of enzyme required to produce an increase of 1 absorbance U per min under the assay conditions described. Enzyme activity is expressed per milligram of extract protein, measured by the method of Bradford (23).

ER binding in MCF-7 cells
A suspension of MCF-7 cells in 10 ml serum-free media was incubated with 10-9 M [3H]E2 alone or in the presence of 2 x 10-7 M unlabeled E2, 10-5 M toxaphene, 10-5 M dieldrin, or 10-5 M dieldrin/toxaphene mixture for 1 h at 37 EC. Cells were harvested by centrifugation and washed with PBS (20 ml x2). Cells were pelleted by centrifugation, resuspended in 2 ml HED buffer (25 mM HEPES, 1.5 mM EDTA, 1 mM dithiothreitol, pH 7.6), incubated on ice for 10 min, and vigorously homogenized using a teflon pestle/drill apparatus. The homogenate was transferred to a centrifuge tube, rinsed with 2 ml HED buffer, and centrifuged at 1500 x g at 4 EC for 15 min, and the supernatant was collected and saved. The pellet was resuspended in 1 ml HEGDK (25 mM HEPES, 1.5 mM EDTA, 10% glycerol, 1 mM dithiothreitol, 0.5 M KCl; pH 7.6) and incubated on ice for 1 h with gentle shaking. After centrifugation at 105,000 x g for 1 h at 4 EC, the supernatant was collected and combined with the supernatant noted above. Samples were then placed on ice and treated with an 0.1 vol DCC suspension (0.5% dextran, 5% charcoal, wt/vol in TESHMo) for 10 min. Samples were then centrifuged at 5,000 x g for 10 min, and the entire supernatant was measured for radioactivity by liquid scintillation counting. The results are expressed as means ± SE for three separate determinations.

Yeast expression/reporter system using the mouse and human ER
The yeast strain BJ2168 (MAT a, prc 1–407, prb 1–1122, pep 4–3, leu 2, trip-1, ura 3–52) was transformed with a yeast expression plasmid containing the wild-type mER cDNA, and a reporter plasmid containing a single vitellogenin estrogen responsive element (ERE) linked to the LacZ gene (25). The transformations were performed using the lithium acetate technique, and the yeast transformants were selected by uracil and/or tryptophan auxotrophy. A yeast culture was grown overnight at 30 EC in complete minimal dropout medium lacking uracil and tryptophan. The yeast culture was diluted to OD600 = 0.3 and grown for 2 h before the addition of the environmental compounds alone or in combination (see Fig. 3Go). The compounds tested in this system were dissolved in dimethyl sulfoxide (DMSO) and 10 µl of an individual compound, or 5 µl each of two compounds were added to 1 ml of yeast culture such that the concentration of DMSO did not exceed 1% by vol. The yeast cultures were grown for an additional 2.5 h before harvesting for measurement of ß-galactosidase (ß-gal) activity.



View larger version (19K):
[in this window]
[in a new window]
 
Figure 3. ß-gal activity induced by environmental compounds using an estrogen-responsive reporter system in yeast expressing mouse ER. Yeast cells expressing wild-type mER were exposed to the environmental chemicals chlordane (C), dieldrin (D), toxaphene (T), and endosulfan (E), individually at 2.5 x 10-5 M (closed bars). The yeast cells also were exposed to the same chemicals individually at 2.5 x 10-7 M (open bars) or in combination at equivalent molar concentrations (see below) reported to produce synergistic induction of half-maximal ß-gal activity (open bars). The final concentrations used for each combination of compounds are: E+D = 10-7 M; E+T = 10-7 M; E+C = 2 x 10-7 M; D+T = 2 x 10-7 M; D+C = 3 x 10-7 M; T+C = 3 x 10-7 M. The yeast cells also were exposed to DES at 10-8 M (closed bar) and 10-9 M (open bar) as a positive transactivation control. The stimulation of ß-gal activity by the compounds is determined as fold stimulation over the background activity induced by DMSO. The yeast cells were exposed to the chemicals for 2.5 h (Fig. 3AGo) or 16 h (Fig. 3BGo) before measurement of ß-gal activity. Each data bar represents the average and SD of four independent measurements.

 
Yeast cells were pelleted by centrifugation and resuspended in 1 ml Z buffer (60 mM Na2HPO4, 40 mM NaH2PO4, 10 mM KCl, 1 mM MgSO4, 40 mM ß-mercaptoethanol, pH 7.0). An aliquot of the suspension was measured for cell density at OD600. A 100-µl aliquot of yeast suspension was then diluted to 1 ml with Z buffer and then treated with 12 µl 0.1% SDS and 15 µl chloroform. The samples were mixed by vortexing and placed at 30 EC for 15 min to permeabilize the cells. Then 200 µl o-nitrophenyl ß-D-galactopyranoside (4 mg/ml in 0.1 M KH2PO4, pH 7.0) were added to the yeast cell suspension and further incubated until chromogenic development. The reactions were stopped by adding 500 µl 1 M Na2CO3 to the samples. Then yeast suspensions were centrifuged to pellet the cellular debris, and the supernatant was analyzed by spectrophotometry at OD420 to quantify ß-gal activity. The activity induced by the various chemical treatments were expressed as fold stimulation divided by the vehicle control value determined with DMSO induction. Measurement of ß-gal activity after 16 h of chemical treatment was performed in a similar manner, except that the overnight yeast culture was initially diluted to OD600 = 0.1 and then immediately incubated in the presence of the chemical compounds.

The yeast strain BJ2407 (a/{alpha} prb1–1122/prb1–1122 prc1–407/prc1–407 pep4–3/pep4/3 leu2/leu2 trp1/trp1 ura3–52/ura3–52) was transformed with the ER expression plasmid YePE10, and a reporter vector YRPE2 containing two copies of the vitellogenin ERE was inserted into the promoter of an enhancerless CYC-1-ß-gal fusion (26, 27). Individual transformants were grown overnight to a density (OD600) of approximately 0.8 and then combined with an equal volume of minimal medium containing copper sulfate (to induce receptor synthesis from the CUP1 promoter), E2, or the compound to be tested. The final concentration of copper sulfate was 50 µM. Increasing concentrations of ligands dissolved in DMSO were tested as indicated in the figure legends. Cells were induced for 24 h in 96-well plates and then lysed, and ß-galactosidase activity was measured. Relative ß-gal units were calculated using the following formula: u = 1000 · [OD420 - (1.75 · OD550)]/(0.1 · OD600 · min).


    Results
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
In vitro studies have reported that both dieldrin and toxaphene are weakly estrogenic and exhibit weak binding to the human ER (5, 6, 18). The results summarized in Fig. 1Go show that neither dieldrin nor toxaphene (10-8–10-5 M) significantly bound to the mouse uterine ER in a competitive binding assay using [3H]E2 as the radioligand. In addition, no significant binding was observed using an equimolar concentration of a dieldrin/toxaphene mixture (Fig. 1Go), and these results contrast with previous studies that reported synergistic binding of this mixture to recombinant baculovirus expressed hER (18). The estrogenic effects of toxaphene, dieldrin, toxaphene plus dieldrin, and E2 were determined in the immature B6C3F1 mouse uterus (Table 1Go). Treatment with E2 (0.0053 µmol/kg·day) resulted in a 3.1-, 4.8-, and 7.8-fold increase in uterine wet weight, peroxidase activity, and PR binding, respectively. At doses of 2.5, 15, and 60 µmol/kg·day (x3), dieldrin did not significantly induce uterine wet weight or PR binding; however, a slight increase in UPO activity was observed only at the intermediate dose of dieldrin (15 µmol/kg). The highest dose of dieldrin used in this study (275 µmol/kg) was lethal to the animals. Similar results were obtained with the dieldrin/toxaphene mixture (275 µmol/kg). The dose-dependent estrogenic effects of toxaphene also were investigated in the immature mouse uterus (Table 1Go). No significant increases were observed in uterine wet weight or PR binding at any of the doses (2.5, 15, 60, and 275 µmol/kg·day). UPO activity was increased slightly at the three lower doses, whereas all the uterine responses were decreased at the 275-µmol/kg dose, and this was caused by some toxicity observed in this treatment group. Immature mice also were cotreated with equimolar doses of toxaphene and dieldrin combined (2.5, 15, and 60 µmol/kg·day x3) to investigate possible synergistic interactions between the two weakly estrogenic pesticides, as previously described (18). The results (Table 1Go) showed that treatment with the binary mixture did not cause a dose-dependent increase in uterine wet weight, peroxidase activity, or PR binding; however, PR levels at the 2.5- and 60-µmol/kg·day dose were significantly induced, whereas no significant induction was observed with the compounds alone.



View larger version (15K):
[in this window]
[in a new window]
 
Figure 1. Competitive binding of organochlorine pesticides to the mouse uterine. Uterine ER was incubated with 10-8 M [3H]E2 and different concentrations of unlabeled E2 (•), toxaphene ({blacktriangleup}), dieldrin ({blacksquare}), and dieldrin/toxaphene ({square}), and the displacement of radiolabeled hormone was determined as described in Materials and Methods. Only unlabeled E2 significantly decreased binding of [3H]E2 to the uterine ER.

 

View this table:
[in this window]
[in a new window]
 
Table 1. Effects of E2, dieldrin (D), toxaphene (T), and dieldrin plus toxaphene (D + T) in the immature B3C3F1 female mouse uterus1

 
Previous studies have reported that both toxaphene and dieldrin were weakly estrogenic in MCF-7 human breast cancer cells (5) and their potencies, relative to E2, were 0.0001. The estrogenic activity of toxaphene, dieldrin, and their combination was investigated in this study in transient transfection studies using two estrogen-responsive constructs, namely CKB-CAT and CATH-CAT, which contain 5'-promoter sequences from the rat CKB and cathepsin D genes linked to a bacterial CAT reporter gene (20, 21). The results summarized in Table 2Go indicate that at concentrations ranging from 10-8–10-5 M, neither toxaphene nor dieldrin induced CAT activity in MCF-7 cells transiently transfected with either the CKB-CAT or CATH-CAT constructs. In contrast, 10-9 M E2 induced a 24-fold increase in CAT activity in MCF-7 cells transiently transfected with CKB-CAT and a 3.8-fold increase in cells transiently transfected with the CATH-CAT construct. Combined treatment of MCF-7 cells with an equimolar mixture of dieldrin plus toxaphene (10-8–10-5 M) resulted in no induced response and was similar to that observed for the individual compounds. The results in Fig. 2Go summarize the concentration-dependent effects of toxaphene, dieldrin, and toxaphene plus dieldrin (equimolar concentrations) on proliferation of MCF-7 cells. There was not a concentration-dependent increase in cell proliferation by either compound alone or the mixture (10-7–10-5 M); however, small but significant increases in cell proliferation were observed for toxaphene and dieldrin plus toxaphene at the 10-7 M concentration. In contrast to both organochlorine pesticides, E2 induced a 6-fold increase in MCF-7 cell proliferation.


View this table:
[in this window]
[in a new window]
 
Table 2. CAT activity in MCF-7 cells treated with E2, dieldrin (D), toxaphene (T), and dieldrin plus toxaphene (D + T), and cotransfected with hER and CKB-CAT or CATH-CAT constructs1

 


View larger version (15K):
[in this window]
[in a new window]
 
Figure 2. Effects of E2 and organochlorine pesticides on proliferation of MCF-7 cells. The cells were treated with 10-9 M E2 (- - - -) or 10-7–10-5 M dieldrin ({diamond}), toxaphene ({circ}), or dieldrin/toxaphene ({blacksquare}) for 11 days, as described in Materials and Methods. The results are presented as means of three separate experiments in which SD < 15%. Significant (*, P < 0.05) induction of cell growth was observed only for 10-7 M toxaphene and 10-7 M dieldrin/toxaphene mixture; 10-9 M E2 caused more than a 6-fold induction in cell proliferation.

 
The relative competitive binding of the organochlorine pesticides was determined by incubating MCF-7 cells with 10-9 M [3H]E2 in the presence or absence of 2 x 10-7 M unlabeled E2 (to determine nonspecific binding), toxaphene (10-5 M), dieldrin (10-5 M), and equimolar concentrations of the dieldrin plus toxaphene mixture (10-5 M). Total cell extracts were obtained, and after treatment with DCC, radioligand-bound ER binding was determined. The results (Table 3Go) demonstrate that binding of [3H]E2 to the ER in MCF-7 cells was not competitively decreased by cotreatment with 10-5 M toxaphene, dieldrin, or the toxaphene/dieldrin mixture, whereas a 200-fold excess of unlabeled E2 caused a 94% decrease in ER binding (the specifically-bound ER was the difference between the total binding minus the binding after competition with unlabeled E2). These results indicate minimal competition by toxaphene, dieldrin, or dieldrin plus toxaphene for the ER in MCF-7 cells using this whole cell-binding assay.


View this table:
[in this window]
[in a new window]
 
Table 3. Competitive binding of E2, dieldrin (D), toxaphene (T), and dieldrin plus toxaphene (D + T) to the ER in MCF-7 cells1

 
Two yeast-based ER assays were used to investigate synergistic interactions of organochlorine pesticides, as previously reported (18). The results in Fig. 3Go summarize the effects of toxaphene, dieldrin, and other pesticides on ß-gal activity in a yeast system using the mER and a reporter plasmid containing a single ERE linked to the LacZ gene (25). At a concentration of 2.5 x 10-7 M, the pesticides did not induce ß-gal activity (Fig. 3AGo), as previously reported using a yeast assay system expressing the hER (18). However, 2.5 x 10-5 M of any compound individually was capable of inducing activity from 1.5-fold (dieldrin) to 4-fold (endosulfan). This induction was approximately 7–18% of the activity induced by 1 x 10-8 M Diethylstilbestrol (DES), which was 22-fold. No synergistic induction by the mER was demonstrated with any of the chemical combinations ranging from 1–3 x 10-7 M. Furthermore, the chemical mixtures did not induce activity above background, as in the case of each compound individually at 2.5 x 10-7 M. Synergistic transactivation also was absent when any two compounds were mixed at the higher concentration (2.5 x 10-5 M) (Fig. 3AGo). The maximum level of activity attained by any chemical alone or in combination at 2.5 x 10-5 M was never above 18% of the level obtained with 1 x 10-8 M DES. This observation directly contrasts with the hER system, which showed that binary mixtures of these compounds synergistically induced up to 65% of the activity observed for 10-8 M E2 (18). A further comparison of mER with the hER (18) yeast-based systems was determined using a longer (16 h) incubation time (Fig. 3BGo). Induction by 10-8 M DES was increased to 71-fold; however, the organochlorine pesticides alone (2.5 x 10-7 M) or in combination (1 to 3 x 10-7 M) were inactive. At higher concentrations (2.5 x 10-5 M), only dieldrin and endosulfan were weakly estrogenic, and synergism was not observed for the binary mixtures.

The estrogenic activity of dieldrin, toxaphene, other organochlorine pesticides, and their binary mixtures also were investigated using yeast transformants containing the human ER plus a reporter gene containing two vitellogenin EREs upstream of the ß-gal gene (26, 27). The cells were treated with increasing concentrations of either E2 as a positive control or endosulfan, chlordane, toxaphene, and dieldrin (singly or in combination) (Fig. 4Go). E2 (10-8 M) induced a 5000-fold increase in ß-gal activity. Of the other chemicals tested, only endosulfan (10-4 M) induced ß-gal activity above background. Equimolar concentrations of combinations of endosulfan, chlordane, toxaphene, and dieldrin did not result in synergistic induction of ß-gal activity. The failure to observe synergistic interactions for dieldrin plus toxaphene and other binary mixtures in the two yeast-based assays (Figs. 3Go and 4Go) was consistent with results observed in the mouse uterus (Fig. 1Go and Table 1Go) and MCF-7 human breast cancer cells (Fig. 2Go and Table 2Go).



View larger version (28K):
[in this window]
[in a new window]
 
Figure 4. ß-gal activity induced by environmental compounds using an estrogen-responsive reporter system in yeast expressing human ER. The experiment was performed as described above, except that yeast strain BJ2407, transformed with a yeast expression plasmid containing the wild-type human ER and a reporter plasmid containing two copies of the vitellogenin ERE linked to the LacZ gene, was used to match experimental conditions reported by Arnold and co-workers (18). The yeast were exposed to environmental chemicals alone or in combination for 24 h in 96-well plates and then assayed for ß-gal activity.

 

    Discussion
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 
Several recent studies have characterized the estrogenic activities of a diverse spectrum of industrial compounds which includes organochlorine pesticides, PCBs, hydroxy PCBs, phthalates, and various phenolics such as nonylphenol and nonylphenol ethoxylates (4, 5, 6, 8, 10, 18, 28). Exposure to persistent organochlorine pollutants has been associated with reproductive problems in some wildlife populations, and it has been hypothesized that endocrine-disrupting properties of these environmental contaminants may be responsible for the adverse developmental effects (1). Environmental levels of most organochlorine pesticides have decreased in North America and other developed countries where their applications have been restricted or banned (29, 30).

Arnold and co-workers (18) recently reported that interactions between weakly estrogenic pesticides such as dieldrin, toxaphene, and endosulfan resulted in enhanced binding to baculovirus-expressed hER and synergistic induction of estrogen-responsive reporter gene activity in a yeast bioassay. It was surprising that toxaphene alone was only weakly estrogenic because toxaphene is a mixture of C10H10Cl8 isomers that undoubtedly exhibit estrogenic and nonestrogenic activities. Interestingly, chlordane also synergistically interacted with the estrogenic pesticides in the same assay system, even though chlordane does not seem to be estrogenic (6, 18). These results have significant mechanistic implications regarding ER-mediated gene expression; moreover, the apparent synergistic effects observed for the weakly estrogenic and nonestrogenic organochlorine pesticides have heightened concern regarding potential environmental and human health implications of exposure to mixtures of environmental contaminants (31, 32). This study was designed to further investigate the estrogenic activity and interactions of toxaphene and dieldrin using three well-characterized models, namely the immature mouse uterus, MCF-7 human breast cancer cells, and the yeast-based ER assay.

The results illustrated in Fig. 1Go demonstrate that toxaphene, dieldrin, and a mixture containing equimolar concentrations of both compounds do not competitively displace [3H]E2 from the mouse uterine ER. A previous study (33) also showed that dieldrin (3 mg/kg x7) and toxaphene (25 mg/kg x7) and several other organochlorine pesticides did not induce a uterine wet weight increase in the immature female rat. In this study, using a standard immature mouse protocol for estrogenicity, toxaphene and dieldrin alone exhibited minimal estrogenic activity. The toxaphene/dieldrin mixture induced a small increase in uterine PR levels (Table 1Go); however, this response was not dose dependent. For the remaining responses, no apparent synergistic interactions were observed for the toxaphene/dieldrin mixture (Table 1Go). These results indicate that there are major differences between the interactive estrogenic effects and ER binding of toxaphene and dieldrin in the mouse uterus (Table 1Go; Fig. 1Go) compared with results obtained with the hER construct used in the baculovirus-expressed system or the yeast assay system used by Arnold and co-workers (18), even though the mouse ER binds with variable affinities to other environmental chemicals such as hydroxy-PCBs (3) and alkylphenols (10).

The potential interactions of toxaphene and dieldrin were investigated further in MCF-7 human breast cancer cells. Soto and co-workers (5) previously reported that both toxaphene and dieldrin induced proliferation of MCF-7 cells in their E-screen assay; however, this response was only induced at the highest concentration (10-5 M). In the present study, 10-5 M toxaphene, 10-5 M dieldrin, and 10-5 M dieldrin plus toxaphene did not induce cell proliferation, whereas 10-9 M E2 caused a 6-fold increase in cell growth (Fig. 2Go). In contrast, other xenoestrogens previously identified as weak estrogens in the E-screen, including nonylphenol, 2',4',6'-trichloro-4-biphenylol and bisphenol-A, induced MCF-7 cell proliferation in our assay system (data not shown). The reason for the differences between results of this study with toxaphene and dieldrin vs. previous reports (5, 6) may be caused by several factors, including cell culture conditions, cell passage number, or serum (34). The estrogenic activity of toxaphene, dieldrin, and toxaphene plus dieldrin also was investigated in transient transfection assays, which used two constructs (CKB-CAT and CATH-CAT) that contain estrogen-responsive 5'-promoter sequences from the CKB and cathepsin D genes (20, 21). In transient transfection studies, E2 significantly induced CAT activity in MCF-7 cells, whereas induction was not observed with toxaphene, dieldrin, or their combination (Table 2Go). These results complement ER-binding studies, which showed that the organochlorine pesticides (alone or in combination) did not competitively bind to the hER in MCF-7 cells (Table 3Go).

The effects of toxaphene, dieldrin, other organochlorine pesticides, and binary mixtures of these compounds also were investigated in yeast-based reporter gene assays (25, 26, 27). The results obtained in yeast transformed with an expression plasmid that contained the wild-type mouse ER and a reporter plasmid containing a single ERE linked to the LacZ gene (Fig. 3Go) indicated that the estrogenic activities of dieldrin and toxaphene were minimal, and no synergistic effects were observed for a binary mixture of these and other organochlorine pesticides. The potential interactions of toxaphene and dieldrin, as well as endosulfan and chlordane, also were investigated in a yeast-based ER assay that used the same yeast strain and reporter gene construct as reported by Arnold and co-workers (18). In contrast to the previous study, synergistic activity was not observed for binary mixtures of toxaphene/dieldrin or other pesticide combinations. Endosulfan exhibited estrogenic activity in both yeast assays; however, binary mixtures of endosulfan plus the other organochlorine compounds did not induce synergistic responses (Figs. 3Go and 4Go). The reasons for the differences between results of this study and that reported by Arnold and co-workers (18) are unclear but may be caused by a unique aspect of the yeast strain maintained in either laboratory or to differences in ER constructs used by either laboratory. The differences could not be accounted for by levels of ER expression because varying the level of ER expression did not alter the results (data not shown). These data (Fig. 4Go) demonstrate that synergism between weakly estrogenic chemicals is not universal, even within the same strain of yeast.

In summary, this study has compared the estrogenic activities of toxaphene, dieldrin, and an equimolar mixture of the two compounds in both ER-binding and functional assays in the mouse uterus, MCF-7 human breast cancer cells, and in estrogen-responsive yeast assays. The activities of both compounds alone were minimal, and no synergistic effects were observed with the binary mixture in the mouse uterus and MCF-7 cells (Tables 1–3GoGoGo; Figs. 1Go and 2Go). Similar results were observed for toxaphene/dieldrin and other binary mixtures of organochlorine insecticides in two yeast-based assays (Figs. 3Go and 4Go). These data contrasted with results reported by Arnold and co-workers (18) in the ER-binding and yeast assays and other studies which have reported nonadditive (synergistic) interactions with hydroxy PCBs and other mixtures of organochlorine pesticides and phenolics (6, 10). It should be noted also that results of previous studies with mixtures of estrogenic/nonestrogenic compounds do not always give synergistic responses. Toxaphene is not a single chemical but a chlorinated camphene mixture containing several C10H10Cl8 isomers that undoubtedly exhibit estrogenic and nonestrogenic activity. However, the toxaphene mixture is only weakly estrogenic or nonestrogenic in both in vitro and in vivo assays (6, 18, 33). Similarly, Aroclor 1221 and nonylphenol also are mixtures of active and inactive congeners, and the estrogenic activities of both mixtures also are relatively weak (5, 6, 7, 10, 35). This suggests that synergistic interactions of weakly estrogenic or nonestrogenic chemicals may be highly structure dependent. Moreover, the results obtained for a binary mixture of dieldrin and toxaphene and other organochlorine pesticides in this study indicate that synergistic interactions are both response- and assay-specific. Thus, the recent scientific, regulatory, and public concern regarding the potential adverse environmental and human health impacts associated with the synergistic effects induced by organochlorine pesticide mixtures (18) should be tempered by the results reported in this study, which show that in 10 different assays, synergistic interactions were not observed (36).


    Footnotes
 
1 This work was supported by NIH Grants ES-04917 and DK-48807, the Chemical Manufacturers Association, and the Texas Agricultural Experiment Station, all of which are gratefully acknowledged. Back

2 A Sid Kyle Professor of Toxicology. Back

Received October 16, 1996.


    References
 Top
 Abstract
 Introduction
 Materials and Methods
 Results
 Discussion
 References
 

  1. Colborn T, Vom Saal FS, Soto AM 1993 Developmental effects of endocrine-disrupting chemicals in wildlife and humans. Environ Health Perspect 101:378–384[Medline]
  2. Birnbaum L 1995 Developmental effects of dioxin. Environ Health Perspect 103:89–94
  3. Korach KS, Sarver P, Chae K, McLachlan JA, McKinney JD 1988 Estrogen receptor-binding activity of polychlorinated hydroxybiphenyls: conformationally restricted structural probes. Mol Pharmacol 33:120–126[Abstract]
  4. Soto AM, Justicia H, Wray JW, Sonnenschein C 1991 p-Nonylphenol: an estrogenic xenobiotic released from "modified" polystyrene. Environ Health Perspect 92:167–173[Medline]
  5. Soto AM, Chung KL, Sonnenschein C 1994 The pesticides endosulfan, toxaphene, and dieldrin have estrogenic effects on human estrogen-sensitive cells. Environ Health Perspect 102:380–383[Medline]
  6. Soto AM, Sonnenschein C, Chung KL, Fernandez MF, Olea N, Serrano FO 1995 The E-screen assay as a tool to identify estrogens - an update on estrogenic environmental pollutants. Environ Health Perspect 103:113–122
  7. Krishnan AV, Stathis P, Permuth SF, Tokes L, Feldman D 1993 Bisphenol-A: an estrogenic substance is released from polycarbonate flasks during autoclaving. Endocrinology 132:2279–2286[Abstract/Free Full Text]
  8. White R, Jobling S, Hoare SA, Sumpter JP, Parker MG 1993 Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology 135:175–182[Abstract]
  9. Jobling S, Reynolds T, White R, Parker MG, Sumpter JP 1995 A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect 103:582–587[Medline]
  10. Sumpter JP, Jobling S 1995 Vitellogenesis as a biomarker for estrogenic contamination of the aquatic environment. Environ Health Perspect [Suppl 7] 103:173–178
  11. Davis DL, Bradlow HL, Wolff M, Woodruff T, Hoel DG, Anton-Culver H 1993 Medical hypothesis: xenoestrogens as preventable causes of breast cancer. Environ Health Perspect 101:372–377[Medline]
  12. Sharpe RM, Skakkebaek NF 1993 Are oestrogens involved in falling sperm counts and disorders of the male reproductive tract. Lancet 341:1392–1395[CrossRef][Medline]
  13. Sharpe RM 1995 Reproductive biology. Another DDT connection. Nature 375:538–539[CrossRef][Medline]
  14. Adami HO, Lipworth L, Titusernstoff L, Hsieh CC, Hanberg A, Ahlborg U, Baron J, Trichopoulos D 1995 Organochlorine compounds and estrogen-related cancers in women. Cancer Causes Control 6:551–566[CrossRef][Medline]
  15. Ahlborg UG, Lipworth L, Titusernstoff L, Hsieh CC, Hanberg A, Baron J, Trichopoulos D, Adami HO 1995 Organochlorine compounds in relation to breast cancer, endometrial cancer, and endometriosis: an assessment of the biological and epidemiological evidence. Crit Rev Toxicol 25:463–531[Medline]
  16. Safe S 1995 Environmental and dietary estrogens and human health - is there a problem? Environ Health Perspect 103:346–351[Medline]
  17. Ekbom A, Wicklund-Glynn A, Adami HO 1996 DDT and testicular cancer. Nature 347:553–554[CrossRef]
  18. Arnold SF, Klotz DM, Collins BM, Vonier PM, Guillette JR LJ, McLachlan JA 1996 Synergistic activation of estrogen receptor with combinations of environmental chemicals. Science 272:1489–1492[Abstract]
  19. Bergeron JM, Crews D, McLachlan JA 1994 PCBs as environmental estrogens: turtle sex determination as a biomarker of environmental contamination. Environ Health Perspect 102:786–791
  20. Redecker B, Heckendorf B, Grosch H, Mersmann G, Hasilik A 1991 Molecular organization of the human cathepsin D gene. DNA Cell Biol 10:423–431[Medline]
  21. Hobson GM, Molloy GR, Benfield PA 1990 Identification of cis-acting regulatory elements in the promoter region of the rat brain creatine kinase gene. Mol Cell Biol 10:6533–6543[Abstract/Free Full Text]
  22. Connor K, Howell J, Chen I, Liu H, Berhane K, Sciarretta C, Safe S, Zacharewski T 1996 Failure of chloro-s-triazine-derived compounds to induce estrogen receptor-mediated responses in vivo and in vitro. Fundam Appl Toxicol 30:93–101[CrossRef][Medline]
  23. Bradford MM 1976 A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254[CrossRef][Medline]
  24. Lyttle CR, DeSombre ER 1977 Uterine peroxidase as a marker for estrogen action. Proc Natl Acad Sci USA 74:3162–3166[Abstract/Free Full Text]
  25. Kohno H, Gandini O, Curtis SW, Korach KS 1994 Anti-estrogens induce estrogen receptor mediated response in yeast. Steroids 59:572–578[CrossRef][Medline]
  26. McDonnell DP, Nawaz Z, Densmore C, Weigel NL, Pham TA, Clark JH, O’Malley BW 1991 High level expression of biologically active estrogen receptor in Saccharomyces cerevisiae. J Steroid Biochem Mol Biol 39:291–297[CrossRef][Medline]
  27. Pham TA, Hwung YP, Santiso-Mere D, McDonnell DP, O’Malley BW 1992 Ligand-dependent and -independent function of the transactivation regions of the human estrogen receptor in yeast. Mol Endocrinol 6:1043–1050[Abstract/Free Full Text]
  28. Krishnan V, Safe S 1993 Polychlorinated biphenyls (PCBs), dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) as antiestrogens in MCF-7 human breast cancer cells: quantitative structure-activity relationships. Toxicol Appl Pharmacol 120:55–61[CrossRef][Medline]
  29. Kutz FW, Wood PH, Bottimore DP 1991 Organochlorine pesticides and polychlorinated biphenyls in human adipose tissue. Rev Environ Contam Toxicol 120:1–82[Medline]
  30. Winter CK 1992 Dietary pesticide risk assessment. Rev Environ Contam Toxicol 127:23–67[Medline]
  31. Kaiser J 1996 Environmental estrogens: new yeast study finds strength in numbers. Science 272:1418[CrossRef][Medline]
  32. Simons SS 1996 Environmental estrogens: can two alrights make a wrong. Science 272:1451–1452[CrossRef][Medline]
  33. Welch RM, Levin W, Kuntzman R, Jacobson M, Conney AH 1971 Effects of halogenated hydrocarbon insecticides on the metabolism and uterotropic action of estrogens in rats and mice. Toxicol Appl Pharmacol 19:234–246[CrossRef][Medline]
  34. Villalobos M, Olea N, Brotons JA, Oleaserrano MF, Dealmodovar JMR, Pedraza V 1995 The E-screen assay - a comparison of different MCF-7 cell stocks. Environ Health Perspect 103:844–850[Medline]
  35. Ecobichon DJ, MacKenzie DO 1974 The uterotropic activity of commercial and isomerically-pure chlorobiphenyls in the rat. Res Commun Chem Pathol Pharmacol 9:85–95[Medline]
  36. Ramamoorthy K, Wang F, Chen I, Norris JD, McDonnell DP, Gaido KW, Bocchinfuso WP, Korach KS, Safe S 1997 Potency of combined estrogenic pesticides. Science 275:405



This article has been cited by other articles:


Home page
Biol. Reprod.Home page
M.-K. I. Anas, C. Guillemette, P. Ayotte, D. Pereg, F. Giguere, and J. L. Bailey
In Utero and Lactational Exposure to an Environmentally Relevant Organochlorine Mixture Disrupts Reproductive Development and Function in Male Rats
Biol Reprod, September 1, 2005; 73(3): 414 - 426.
[Abstract] [Full Text] [PDF]


Home page
Toxicol SciHome page
G. D. Charles, C. Gennings, T. R. Zacharewski, B. B. Gollapudi, and E. W. Carney
An Approach for Assessing Estrogen Receptor-Mediated Interactions in Mixtures of Three Chemicals: A Pilot Study
Toxicol. Sci., August 1, 2002; 68(2): 349 - 360.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Demers, P. Ayotte, J. Brisson, S. Dodin, J. Robert, and E. Dewailly
Risk and Aggressiveness of Breast Cancer in Relation to Plasma Organochlorine Concentrations
Cancer Epidemiol. Biomarkers Prev., February 1, 2000; 9(2): 161 - 166.
[Abstract] [Full Text]


Home page
Toxicol SciHome page
T. J. Schrader and G. M. Cooke
Examination of Selected Food Additives and Organochlorine Food Contaminants for Androgenic Activity in Vitro
Toxicol. Sci., February 1, 2000; 53(2): 278 - 288.
[Abstract] [Full Text] [PDF]


Home page
Toxicol Ind HealthHome page
E. Hodgson
Induction and inhibition of pesticide-metabolizing enzymes: roles in synergism of pesticides and pesticide action
Toxicology and Industrial Health, February 1, 1999; 15(1-2): 6 - 11.
[Abstract] [PDF]


Home page
Toxicol Ind HealthHome page
F. Olea-Serrano, P. Lardelli-Claret, A. Rivas, A. Barba-Navarro, and N. Olea
Inadvertent exposure to xenoestrogens in children
Toxicology and Industrial Health, February 1, 1999; 15(1-2): 152 - 159.
[Abstract] [PDF]


Home page
Toxicol Ind HealthHome page
C. M. Merritt, L. Torrentera, K. M. Winter, C. K. Tornehl, K. Girvin, and S. I. Dodson
Dieldrin reduces male production and sex ratio in Daphnia galeata mendotae
Toxicology and Industrial Health, February 1, 1999; 15(1-2): 193 - 200.
[Abstract] [PDF]


Home page
CarcinogenesisHome page
K. Ramamoorthy, M. S. Gupta, G. Sun, A. McDougal, and S. H. Safe
3,3',4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells
Carcinogenesis, January 1, 1999; 20(1): 115 - 123.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
G. G. J. M. Kuiper, J. G. Lemmen, B. Carlsson, J. C. Corton, S. H. Safe, P. T. van der Saag, B. van der Burg, and J.-A. Gustafsson
Interaction of Estrogenic Chemicals and Phytoestrogens with Estrogen Receptor {beta}
Endocrinology, October 1, 1998; 139(10): 4252 - 4263.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ramamoorthy, K.
Right arrow Articles by Safe, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ramamoorthy, K.
Right arrow Articles by Safe, S.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals